| Investigation of factors influencing radioiodine (131I) biokinetics in patients with benign thyroid disease using nonlinear mixed effects approach V Topić Vučenović, Z Rajkovača, D Jelić, D Stanimirović, G Vuleta, ... European Journal of Clinical Pharmacology 74, 1037-1045, 2018 | 8 | 2018 |
| Concept and utility of population pharmacokinetic and pharmacokinetic/pharmacodynamic models in drug development and clinical practice M Roganović, A Homšek, M Jovanović, VT Vučenović, M Ćulafić, ... Archives of Pharmacy 71 (Notebook 4), 336-353, 2021 | 7 | 2021 |
| TLC determination of glimepiride and its main impurities in pharmaceuticals V Topić, S Filipić, G Popović, K Nikolić, D Agbaba Journal of Liquid Chromatography & Related Technologies 36 (17), 2422-2430, 2013 | 7 | 2013 |
| Population exposure-response model of 131I in patients with benign thyroid disease VT Vučenović, Z Rajkovača, D Jelić, D Stanimirović, M Mikov, B Miljković, ... European Journal of Pharmaceutical Sciences 165, 105942, 2021 | 4 | 2021 |
| Investigation of influence of anti-thyroid drug discontinuation time on I-131 biokinetics in patients with benign thyroid disease V Topić-Vučenović, K Vučićević, Z Rajkovača, D Stanimirović, G Vuleta, ... European Journal of Nuclear Medicine and Molecular Imaging 44 (Supplement 2 …, 2017 | 4 | 2017 |
| Phytosynthesis of zinc oxide nanoparticles with acetonic extract of flowers of Geranium robertianum L. (Geraniaceae). R Suručić, A Šmitran, D Gajic, L Božic, M Antic, V Topić-Vučenovic, ... | 3 | 2021 |
| Challenges and current views on dosing of radioactive iodine in the treatment of benign thyroid disease V Topić-Vučenović, Z Rajkovača, S Vezmar-Kovačević, B Miljković, ... Arhiv za farmaciju 67 (6), 333-344, 2017 | 3 | 2017 |
| Integrating Clopidogrel’s First-Pass Effect in a Joint Semi-Physiological Population Pharmacokinetic Model of the Drug and Its Inactive Carboxylic Acid Metabolite Z Pejčić, V Topić Vučenović, B Miljković, KM Vučićević Pharmaceutics 16 (5), 685, 2024 | | 2024 |
| Razvoj populacionog biokinetičkog i dinamičkog modela radioaktivnog joda (131I) i primena u optimizaciji doziranja kod pacijenata sa benignim oboljenjem štitaste žlezde V Topić Vučenović Универзитет у Београду, 2021 | | 2021 |
| The influence of biologically effective dose (BED) on the 131I therapy response in patients with benign thyroid disease–nonlinear mixed effect modelling approach V Topić Vučenović, Z Rajkovača, D Jelić, D Stanimirović, M Mikov, ... Population Approach Group of Australia & New Zeland Abstracts (PAGANZ), 2021 | | 2021 |
| Koncept i upotreba populacionih farmakokinetičkih i farmakokinetičko/farmakodinamičkih modela u razvoju leka i kliničkoj praksi M Roganović, A Homšek, M Jovanović, V Topić-Vučenović, M Ćulafić, ... Arhiv za farmaciju 71 (4), 336-353, 2021 | | 2021 |
| Clinically important drug interactions with opioid and non-opioid analgesics S Vezmar-Kovačević, K Vučićević, V Topić-Vučenović, Z Rajkovača, ... Arhiv za farmaciju 69 (1), 1071-1083, 2019 | | 2019 |
| Klinički značajne interakcije opioidnih i neopioidnih analgetika S Vezmar-Kovačević, K Vučićević, V Vučenović-Topić, Z Rajkovača, ... Arhiv za farmaciju 68 (6), 1071-1083, 2018 | | 2018 |
| Challenges and current views on dosing of radioactive iodine in the treatment of benign thyroid disease VV Topić, Z Rajkovača, KS Vezmar, B Miljković, K Vučićević Arhiv za farmaciju 67 (6), 333-344, 2017 | | 2017 |
